Alzheimer's Dementia

 Alzheimer's Dementia is a topic that anyone of us should think about, because when growing old, everyone could be affected.Memantine.com | Alzheimer's Dementia: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Alzheimer's Dementia Merz GmbHAlzheimer's Dementia Merz - our research for your health. If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. Alzheimer's Dementia: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Dementia is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's Dementia now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's Dementia very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Dementia and Merz means research for your health. High-quality products and information about Alzheimer's Dementia can be found on our website. Visit us online and learn everything about Alzheimer's Dementia from one of Germany's leading health care companies. Our contribution to Alzheimer's Dementia: read here what we can do for you. Further links: Axura: Information for professionals.>>  Alzheimer's Dementia Merz GmbH Memantine.com | Alzheimer's Dementia: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Alzheimer's Dementia: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Dementia Merz GmbHAlzheimer's Dementia The care for elderly people and their diseases are a topic for our society, whose importance grows each day.Memantine.com | Alzheimer's Dementia: Here you get information about forms of diseases, drugs, therapies, care and latest research results. Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Memantine has been developed as a monotherapeutic. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease. Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Calcium enters into the cell, and through secondary processes, the signal is recognized. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memantine is well tolerated even in long-term therapy. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's . Alzheimer's Dementia Merz - our research for your health. Alzheimer's Dementia
Merz Logo
Merz
Merz visuell
 


This page has moved permanently. You will be redirected to our new website. If not, your browser does not support JavaScript. Please activate JavaScript. Details below.

>> Start >>


Microsoft Internet Explorer (version 5.0 and later)
Open the menu "Tools", choose "Internet options" and go to the tab "Security". Then click on the button "Custom Level" and scroll down to the setting "Active Scripting" and select "Activate".


Netscape Navigator (version 4.7 and later)
In the "Edit"-menu choose the item "preferences". Open the item "Extended" and activate the control button "activate JavaScript".

 
Merz GmbH Alzheimer's DementiaAlzheimer's Dementia Merz - our research for your health. Alzheimer's Dementia Alzheimer's Dementia Merz - our research for your health. Inform yourself about Alzheimer's Dementia now.